Condition
Acute Lymphoblastic Leukemia Not Having Achieved Remission clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Acute Lymphoblastic Leukemia Not Having Achieved Remission clinical trials that are recruiting, at sites in 2 countries (most in Jordan (1), United Kingdom (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Point-of-care MB-CART19.1 CAR-T therapy for relapsed or refractory B‑ALL
This will test whether autologous, point-of-care manufactured CD19-directed CAR-T cells (MB-CART19.1) can treat children and adults with relapsed or refractory B‑cell acute lymphoblastic leukemia.
-
Understanding why CAR T cells don't last in leukemia treatment
This study looks at kids and young adults with leukemia to see why CAR T cells don't stick around long enough after treatment and what might help them last longer.
Related topics
Quick answers
How many Acute Lymphoblastic Leukemia Not Having Achieved Remission clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Jordan (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.